Stay updated on DX-2930 Multiple Dose Study in Hereditary Angioedema Clinical Trial
Sign up to get notified when there's something new on the DX-2930 Multiple Dose Study in Hereditary Angioedema Clinical Trial page.

Latest updates to the DX-2930 Multiple Dose Study in Hereditary Angioedema Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a government funding status notice and updated the version to v3.2.0; removed the previous version tag v3.1.0.SummaryDifference3% 
- Check33 days agoChange DetectedRemoved several drug-safety and pharmaceutical quality topics and updated version to v3.1.0. Core content areas and safety-related topics were reduced.SummaryDifference0.8% 
- Check47 days agoChange DetectedUpdated the page from v3.0.1 to v3.0.2; removed the 'Back to Top' link. No other substantive changes (pricing, stock, or time-slot information).SummaryDifference0.2% 
- Check55 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2% 
- Check62 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific drug information related to Lanadelumab and the inclusion of new facility and location details, while removing previous location references.SummaryDifference3% 
- Check76 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1% 
Stay in the know with updates to DX-2930 Multiple Dose Study in Hereditary Angioedema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DX-2930 Multiple Dose Study in Hereditary Angioedema Clinical Trial page.